Bicuspid aortic valve
Bicuspid aortic valve is the most common congenital heart defect, driving early degenerative valve disease and a distinct aortopathy independent of valve function; management tracks the predominant lesion (stenosis or regurgitation) plus lifelong surveillance of the ascending aorta with defined surgical thresholds.
- Topic reviewThe full article, organized the way the exam asks it.
- ABIM-format MCQsVignettes with an explanation for every wrong answer.
- Key factsThe numbers and thresholds worth memorizing, up front.
- AI tutorMedBrain answers the question you're stuck on.
What this article covers
- Overview
Bicuspid aortic valve (BAV) is the most common congenital heart defect, in which the aortic valve forms with two functional cusps instead of three, with abnormal shear forces predisposing the leaflets to early fibrosis and calcification.
- Epidemiology
Affects approximately 1% to 2% of the general population, the most common congenital heart defect, inherited in an autosomal dominant pattern with a male-to-female ratio of approximately 3:1.
- Risk factors
First-degree relatives of a patient with bicuspid aortic valve, given its autosomal dominant heritability.
- Pathophysiology
Abnormal leaflet shear stress from the bicuspid geometry accelerates fibrosis and calcific degeneration, producing valve disease decades before the wear-related calcification of a normal trileaflet valve.
- Clinical features
An incidental systolic ejection murmur discovered in adolescence or young adulthood, often the first clue, with gradual progression to severe valve disease by the fifth or sixth decade.
- Differential diagnosis
Degenerative (trileaflet) calcific aortic stenosis: similar late-peaking murmur and pulsus tardus, but onset after age 65, no antecedent ejection click, and a trileaflet valve on echocardiography.
- Diagnosis
The diagnosis is confirmed by transthoracic echocardiography (TTE) demonstrating bicuspid morphology (two functional cusps, often with an ejection click when pliable) plus formal grading of valve…
- Management
Management is determined by the predominant lesion type (stenosis or regurgitation) and its severity, following the same framework as for a trileaflet valve; see aortic-stenosis and aortic-regurgitation for full lesion-specific protocols.
- Complications
Aortic dissection, the most feared complication: a 6% lifetime risk, approximately 9 times that of the general population with a trileaflet valve.
- Prognosis
Once aortic stenosis becomes severe, the natural history turns unfavorable quickly: 75% of asymptomatic patients die or develop symptoms within 5 years; once symptoms occur, life expectancy is…
- Prevention
Screen first-degree relatives of every patient with bicuspid aortic valve using echocardiography, given its autosomal dominant heritability, particularly when the proband also has aortopathy.
Read the whole article
Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.
Related articles
- Aortic stenosis
Aortic stenosis is obstruction to left ventricular outflow from a narrowed aortic valve, most often calcific degeneration in older adults or a bicentric bicuspid valve earlier in life. Symptoms of angina, syncope, or heart failure mark a poor prognosis, and severe symptomatic disease is treated with valve replacement (surgical or transcatheter).
- Aortic regurgitation
Aortic regurgitation is diastolic backflow of blood from the aorta into the left ventricle from valve or aortic root disease. Chronic disease causes volume overload with a wide pulse pressure and a decrescendo diastolic murmur, while acute severe regurgitation is a surgical emergency; severe symptomatic or decompensating disease is treated with valve replacement.
- Aortic dissection
Aortic dissection is a tear in the aortic intima allowing blood to split the media, creating a false lumen, and is a surgical emergency. Type A (ascending) dissection needs emergency surgery, while type B (descending) is usually managed medically with rapid heart-rate and blood-pressure control; the priority is impulse control with a beta-blocker first.
- Thoracic aortic aneurysm
Thoracic aortic aneurysm is dilation of the thoracic aorta, often related to hypertension, atherosclerosis, bicuspid aortic valve, or connective tissue disease. Usually asymptomatic, it risks dissection and rupture, so management is blood pressure control, surveillance imaging, and elective repair at size thresholds that are lower in heritable aortopathy.
- Coarctation of the aorta
Coarctation of the aorta is a congenital narrowing of the aorta, usually just distal to the left subclavian artery, causing upper-limb hypertension with reduced, delayed lower-limb pulses. Critical neonatal coarctation is duct-dependent, while older children and adults present with hypertension; treatment is surgical or catheter-based repair.
- Infective endocarditis
Infective endocarditis is microbial infection of the endocardium, usually a heart valve, producing vegetations that cause valve destruction, embolism, and systemic infection. Diagnosis uses the modified Duke criteria combining blood cultures and echocardiography, and treatment is prolonged targeted intravenous antibiotics with surgery for complications.
- Turner syndrome
Turner syndrome is a 45,X (or mosaic-variant) chromosomal disorder causing gonadal dysgenesis, short stature, and a characteristic phenotype including webbed neck, coarctation of the aorta, and horseshoe kidney. Karyotype confirms the diagnosis, and management centers on growth hormone in childhood and estrogen-based pubertal induction with lifelong cardiovascular and metabolic surveillance.
- Marfan syndrome
Marfan syndrome is an autosomal dominant connective tissue disorder from FBN1 (fibrillin-1) mutations, with skeletal, ocular, and cardiovascular features. The cardiovascular risk drives prognosis: aortic root dilation predisposing to dissection and rupture, managed with beta-blockers or ARBs, activity restriction, surveillance imaging, and prophylactic aortic surgery.
- Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy is an autosomal dominant sarcomere disease causing unexplained left ventricular hypertrophy, often with dynamic left ventricular outflow tract obstruction, and is a leading cause of sudden cardiac death in young people. Diagnosis is by echocardiography or cardiac MRI showing unexplained hypertrophy, and management includes negative inotropes, obstruction relief, and ICD placement for high sudden-death risk.
- Mitral valve prolapse
Mitral valve prolapse is systolic displacement of one or both mitral leaflets into the left atrium, usually from myxomatous degeneration, marked by a mid-systolic click and a late systolic murmur. Most cases are benign, but it is the leading cause of primary mitral regurgitation and a small subset carry arrhythmic risk. Management is reassurance for benign disease, beta-blockers for symptoms, and mitral valve repair for severe regurgitation.